Friday, December 16, 2016

BRIEF-Amgen receives positive response from EMA for its single-dose delivery injection Repatha

* Top-line results from approximately 27,500-patient

event-driven fourier study are anticipated in q1 of 2017

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)